Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicities”

436 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 436 results

Post-approval studies (Phase 4)Looking for participantsNCT07195344
What this trial is testing

Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.

Who this might be right for
Locally Advanced or Metastatic Breast Cancers
Institut Claudius Regaud 210
Not applicableLooking for participantsNCT07148245
What this trial is testing

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Who this might be right for
Cutaneous MelanomaCutaneous Melanoma, Stage IIICutaneous Melanoma by AJCC V7 Stage+1 more
University of California, San Francisco 300
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableUnknownNCT06334445
What this trial is testing

CARDIOCARE Prospective Clinical Study

Who this might be right for
Breast Cancer
European Institute of Oncology 736
Not applicableStudy completedNCT02195960
What this trial is testing

Supplementation With Dietary Anthocyanins and Side Effects of Radiotherapy for Breast Cancer

Who this might be right for
Toxicity Due to Radiotherapy
Neuromed IRCCS 242
Not applicableActive Not RecruitingNCT01802346
What this trial is testing

Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

Who this might be right for
Breast CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Southern California 130
Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT04617730
What this trial is testing

Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.

Who this might be right for
RadiodermatitisRadiation ToxicityRadiotherapy Side Effect
Jules Bordet Institute 35
Not applicableEnded earlyNCT00352872
What this trial is testing

Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

Who this might be right for
Breast Cancer
Indiana University 23
Large-scale testing (Phase 3)Study completedNCT00006481
What this trial is testing

Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerSkin Reactions Secondary to Radiation Therapy
Radiation Therapy Oncology Group
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Testing effectiveness (Phase 2)UnknownNCT04759664
What this trial is testing

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Who this might be right for
EGFRI Induced Acneiform Lesions
Lutris Pharma Ltd. 117
Not applicableStudy completedNCT02142907
What this trial is testing

Evaluation of Two Boost Radiation Schedules in Post Lumpectomy Early Stage Carcinoma Breast

Who this might be right for
Breast CancerAdverse Effect of Radiation Therapy
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04486118
What this trial is testing

Centrally Acting ACE Inhibition in SLE

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 36
Not applicableStudy completedNCT07407192
What this trial is testing

Toxicity Outcomes of Simultaneous Integrated Boost in Adjuvant Breast Radiotherapy Acronym

Who this might be right for
Breast Cancer
Institute of Oncology Ljubljana 93
Not applicableLooking for participantsNCT04342546
What this trial is testing

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction

Who this might be right for
Breast CancerCapsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399029
What this trial is testing

Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities

Who this might be right for
ExanthemaLichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
University of Zurich 22
Early research (Phase 1)Study completedNCT00668512
What this trial is testing

Intratumoral Injection Of Alpha-Gal Glycosphingolipids

Who this might be right for
Metastatic Melanoma
University of Massachusetts, Worcester 12
Not applicableStudy completedNCT01316328
What this trial is testing

Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery

Who this might be right for
Breast Cancer
Regina Elena Cancer Institute
Not applicableNot Yet RecruitingNCT07183267
What this trial is testing

Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy

Who this might be right for
Radio DermatitisMucositis OralOesophagitis
The Christie NHS Foundation Trust 248
Next Page